Imperial Brands Stock (OTC:IMBBF), Trade Ideas

Imperial Brands

Imperial Brands is the world's fourth-largest international tobacco company (excluding China National Tobacco) with total fiscal 2023 volume of 198 billion cigarettes sold in more than 160 countries. The firm holds a leading global position in the fine-cut tobacco and hand-rolling paper categories, and it has a logistics platform in Western Europe, Altadis. Through acquisition, Imperial is the third-largest manufacturer in the US and owns the Winston and blu brands.

Cannabis

Penny Stocks

Small Cap

Markets

AVCNF

BAYRY

CRON

IMBBF

JAZZ

MDLZ

TEVA

TLRY

This article was originally published on The Bluntness, and appears here with permission. 

As more big business movers and shakers appear to be ratcheting up their incursions into the cannabis industry, industry advocates are stepping up their defense. 

Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table

Analyst Color

Price Target

Reiteration

Analyst Ratings

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CNBS

THCX

YOLO

Auxly Cannabis Group Inc. (OTCQX: CBWTF) has been &#34;flying under the radar,&#34; according to a recent anal

Auxly Analyst: Cannabis Stock Is &#39;Flying Under The Radar&#39;

News

Intraday Update

Movers

Trading Ideas

AAEEF

AAVMY

ABEV

ABGSF

ABMD

ABTX

ACCFF

ACCYY

ACHV

ACNB

ACRFF

ACRGF

ACSAY

ACST

ACTG

ADMA

ADTN

ADVZF

AERI

AFLYY

AGCO

AGEEF

AGESY

AGLXY

AHFD

AHKSY

AHOTF

AICAF

AINV

AIPUY

AIRG

AIRYY

AISSF

AKO-A

AKZOY

ALDX

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALEX

Allianz Ag Muenchen Namen-Akt Vinkuliert Shares

ALIZF

ALLY

ALOT

ALSN

ALTM

ALXEF

ALXN

AMCR

AMHPF

AMKBF

AMKBY

AMNB

AMPH

AMRN

AMSLF

ANAT

ANGO

ANIP

Australia and New Zealand Banking Group Limited

ANZBY

ANZFF

APELY

APEX

APHA

APTS

ARCB

ARCC

ARGGY

ARGO

ARLP

ARNA

ARNGF

AROC

ARREF

ARRRF

Stocks That Hit 52-Week Lows On Friday

IMPERIAL BRANDS PLC ORD by Imperial Brands PLC

Imperial Brands PLC

WIIM

VINC

Vincerx Pharma shares are trading lower after the company announced a proposed underwritten public offering of common stock and warrants.

ROKU

Roku shares are trading lower, reversing after gaining late Thursday on Q1 earnings.

<p>iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLK#NASDAQ">ICLK</a>), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, today announced the termination of the previously announced agreement and plan of merger, dated as of November 24, 2023 (the "Merger Agreement"), by and among the Company, TSH Investment Holding Limited (the "Parent") and TSH Merger Sub Limited (the "Merger Sub").</p>
<p>&nbsp;</p>
<p>On March 29, 2024, the Company delivered to the Parent a notice (the "Closing Notice") confirming the satisfaction of the closing conditions under the Merger Agreement (other than those conditions that by their nature are to be satisfied by actions taken at the Closing as defined below) and that the Company is ready, willing and able to consummate the closing contemplated under the Merger Agreement (the "Closing").&nbsp; Since the delivery of the Closing Notice, the Company has been communicating and cooperating with the Parent, Merger Sub and their representatives towards the Closing, but the Parent and Merger Sub have failed to complete the Closing within ten (10) Business Days following the delivery date of the Closing Notice pursuant to Section 8.03(b) of the Merger Agreement.&nbsp;</p>
<p>On April 26, 2024, the Company (acting upon the recommendation of the Special Committee) sent a notice of termination to the Parent and the Merger Sub pursuant to Section 8.03(b) of the Merger Agreement, notifying the Parent and the Merger Sub that the Company is exercising its right to terminate the Merger Agreement pursuant to Section 8.03(b) of the Merger Agreement and demanding the Parent to pay the US$1,800,000 termination fee pursuant to Section 8.06(b) of the Merger Agreement by May 9, 2024.&nbsp; &nbsp;As a result of the termination of the Merger Agreement, the proposed merger will not be completed.&nbsp;</p>


Contracts

ICLK

iClick Interactive Asia Group Limited Announces Termination Of Merger Agreement

<p>Baird  analyst Eric Coldwell   maintains Icon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>) with a Outperform and raises the price target from $362 to $363.</p>


ICLR

Baird Maintains Outperform on Icon, Raises Price Target to $363

<p>Rosenblatt  analyst Barton Crockett   maintains Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) with a Neutral and raises the price target from $12 to $14.</p>


SNAP

Rosenblatt Maintains Neutral on Snap, Raises Price Target to $14

<p>&quot;Fiscal year 2024 is shaping up to be another great year of financial performance, and we&#39;re on track to achieve our long-term financial targets,&quot; said Jennifer Walter, CFO. &quot;This year, our sales will grow by&nbsp;7%, our adjusted operating margin will expand by 150 basis points and our adjusted earnings per share will increase by&nbsp;18%.&quot;</p>


Guidance

MOG/A

Moog Raised FY24 Net Sales Outlook To $3.55B (From $3.50B) Vs. $3.51B Est.; Adj. EPS to $7.25 (From $6.90) Vs. $6.94 Est.

<p>Trinet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNET#NYSE">TNET</a>) reported quarterly earnings of $2.16 per share which missed the analyst consensus estimate of $2.46 by 12.2 percent. This is a 13.25 percent decrease over earnings of $2.49 per share from the same period last year.  The company reported quarterly sales of $1.26 billion which missed the analyst consensus estimate of $1.27 billion by 0.47 percent.  This is a 1.44 percent increase over sales of $1.25 billion the same period last year.</p>


Earnings

Earnings Misses

TNET

Trinet Group Q1 Adj $2.16 Misses $2.46 Estimate, Sales $1.26B Miss $1.27B Estimate

<p>Baird  analyst Michael Bellisario   maintains Wyndham Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WH#NYSE">WH</a>) with a Outperform and raises the price target from $86 to $88.</p>


Baird Maintains Outperform on Wyndham Hotels & Resorts, Raises Price Target to $88

<p>Rosenblatt  analyst Blair Abernethy   maintains Pegasystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) with a Buy and maintains $75 price target.</p>


PEGA

Rosenblatt Maintains Buy on Pegasystems, Maintains $75 Price Target

GrafTech International shares are trading higher after the company reported better-than-expected Q1 financial results.

<p>Baird  analyst Peter Benedict   downgrades Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) from Outperform to Neutral and raises the price target from $80 to $87.5.</p>


Downgrades

HIBB

Baird Downgrades Hibbett to Neutral, Raises Price Target to $87.5

<p>Gentex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNTX#NASDAQ">GNTX</a>) reported quarterly earnings of $0.47 per share which met the analyst consensus estimate. This is a 11.9 percent increase over earnings of $0.42 per share from the same period last year.  The company reported quarterly sales of $590.225 million which missed the analyst consensus estimate of $598.011 million by 1.30 percent.  This is a 7.17 percent increase over sales of $550.761 million the same period last year.</p>


GNTX

Gentex Q1 2024 GAAP EPS $0.47, Inline, Sales $590.225M Miss $598.011M Estimate

<p>Rosenblatt  analyst Barton Crockett   maintains Roku (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) with a Neutral and maintains $89 price target.</p>


Rosenblatt Maintains Neutral on Roku, Maintains $89 Price Target

Offerings

CTXR

Citius Pharmaceuticals Announces $15M Registered Direct Offering

<p>First Hawaiian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FHB#NASDAQ">FHB</a>) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.41 by 2.44 percent. This is a 19.23 percent decrease over earnings of $0.52 per share from the same period last year.  The company reported quarterly sales of $205.798 million which beat the analyst consensus estimate of $203.733 million by 1.01 percent.  This is a 4.84 percent decrease over sales of $216.270 million the same period last year.</p>


Earnings Beats

First Hawaiian Q1 2024 GAAP EPS $0.42 Beats $0.41 Estimate, Sales $205.798M Beat $203.733M Estimate

<p>In the last three months, 11 analysts have published ratings on Arhaus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARHS#NASDAQ">ARHS</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $16.86, with a high estimate of $21.00 and a low estimate of $14.50. Witnessing a positive shift, the current average has risen by 19.57% from the previous average price target of $14.10.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714132885_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Arhaus. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$17.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Curtis Nagle</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$17.00</td>
<td>$14.50</td>
</tr>
<tr>
<td>Jeremy Hamblin</td>
<td>Craig-Hallum</td>
<td>Raises</td>
<td>Buy</td>
<td>$21.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$19.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Jonathan Matuszewski</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$17.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Peter Benedict</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$16.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Seth Sigman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$17.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$15.00</td>
<td>-</td>
</tr>
<tr>
<td>Curtis Nagle</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$14.50</td>
<td>$13.50</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$15.00</td>
<td>$13.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Arhaus. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Arhaus compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Arhaus's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Arhaus's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ARHS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Arhaus analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>All You Need to Know About Arhaus</h2>
<p>Arhaus Inc is a growing lifestyle brand and omnichannel retailer of premium home furniture. The company offers merchandise in a number of categories, including furniture, outdoor, lighting, textiles, and decor through its Retail and eCommerce sales channels.</p>
<h3>Financial Insights: Arhaus</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Arhaus faced challenges, resulting in a decline of approximately <strong>-3.46%</strong> in revenue growth as of 31 December, 2023. This signifies a reduction in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Arhaus's net margin excels beyond industry benchmarks, reaching <strong>9.07%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Arhaus's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>9.62%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Arhaus's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.8%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>1.36</strong>, caution is advised due to increased financial risk.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ARHS

Assessing Arhaus: Insights From 11 Financial Analysts

<p>6 analysts have expressed a variety of opinions on Qualys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Qualys, revealing an average target of $179.0, a high estimate of $210.00, and a low estimate of $152.00. A decline of 8.67% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714132877_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Qualys by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Announces</td>
<td>Sector Perform</td>
<td>$172.00</td>
<td>-</td>
</tr>
<tr>
<td>Nick Yako</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Hold</td>
<td>$170.00</td>
<td>-</td>
</tr>
<tr>
<td>Brian Essex</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$152.00</td>
<td>$146.00</td>
</tr>
<tr>
<td>Brian Colley</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$190.00</td>
<td>-</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$180.00</td>
<td>$212.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$210.00</td>
<td>$230.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Qualys. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Qualys compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Qualys's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Qualys's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/QLYS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Qualys analyst ratings.</strong></a></p>
<h2>All You Need to Know About Qualys</h2>
<p>Qualys Inc. is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-sized businesses. Qualys was founded in 1999 and went public in 2012.</p>
<h3>Qualys's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> Qualys displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately <strong>10.49%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Qualys's net margin excels beyond industry benchmarks, reaching <strong>28.08%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Qualys's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>11.75%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Qualys's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>5.19%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Qualys's debt-to-equity ratio is below the industry average. With a ratio of <b>0.08</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


QLYS

Deep Dive Into Qualys Stock: Analyst Perspectives (6 Ratings)

<p>In the latest quarter, 4 analysts provided ratings for Dow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $61.75, along with a high estimate of $68.00 and a low estimate of $58.00. This upward trend is apparent, with the current average reflecting a 7.86% increase from the previous average price target of $57.25.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714132864_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Dow. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$61.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$68.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$58.00</td>
<td>$55.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Dow. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Dow compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Dow's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Dow's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/DOW/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Dow analyst ratings.</strong></a></p>
<h2>Get to Know Dow Better</h2>
<p>Dow Chemical is a diversified global chemicals producer, formed in 2019 as a result of the DowDuPont merger and subsequent separations. The firm is a leading producer of several chemicals, including polyethylene, ethylene oxide, and silicone rubber. Its products have numerous applications in both consumer and industrial end markets.</p>
<h3>Key Indicators: Dow's Financial Health</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Challenges:</strong> Dow's revenue growth over 3 months faced difficulties. As of 31 December, 2023, the company experienced a decline of approximately <strong>-10.44%</strong>. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>-1.02%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Dow's ROE excels beyond industry benchmarks, reaching <strong>-0.57%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Dow's ROA excels beyond industry benchmarks, reaching <strong>-0.19%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Dow's debt-to-equity ratio is below the industry average. With a ratio of <b>0.88</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


4 Analysts Assess Dow: What You Need To Know

<p>4 analysts have expressed a variety of opinions on Lincoln Electric Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LECO#NASDAQ">LECO</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $253.0, along with a high estimate of $280.00 and a low estimate of $239.00. Marking an increase of 8.12%, the current average surpasses the previous average price target of $234.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714132848_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>A comprehensive examination of how financial experts perceive Lincoln Electric Holdings is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mircea Dobre</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$252.00</td>
<td>$257.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$241.00</td>
<td>$239.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$239.00</td>
<td>$208.00</td>
</tr>
<tr>
<td>Steve Barger</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$280.00</td>
<td>$232.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Lincoln Electric Holdings. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Lincoln Electric Holdings compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Lincoln Electric Holdings's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Lincoln Electric Holdings's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/LECO/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Lincoln Electric Holdings analyst ratings.</strong></a></p>
<h2>Get to Know Lincoln Electric Holdings Better</h2>
<p>Lincoln Electric is a leading manufacturer of welding, cutting, and brazing products. The firm's portfolio of products includes arc-welding solutions, plasma and oxy-fuel cutting systems, and brazing and soldering alloys, as well as automation solutions. Lincoln Electric serves clients in the general fabrication, heavy industries, automotive, construction, shipbuilding, energy and process industries, among other end markets. Based in Cleveland, Ohio, Lincoln Electric has operations in 19 countries and has 11,000 employees worldwide. The company generated roughly $4.2 billion in sales in 2023.</p>
<h3>Financial Milestones: Lincoln Electric Holdings's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Lincoln Electric Holdings's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately <strong>13.7%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Lincoln Electric Holdings's net margin is impressive, surpassing industry averages. With a net margin of <strong>14.8%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>12.36%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>4.67%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Lincoln Electric Holdings's debt-to-equity ratio surpasses industry norms, standing at <strong>0.84</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


LECO

Peeling Back The Layers: Exploring Lincoln Electric Holdings Through Analyst Insights

SLCA

U.S. Silica Holdings shares are trading higher after the company reported Q1 financial results and entered into a definitive agreement to be acquired by funds managed by affiliates of Apollo.

Tobacco earnings are coming - time for a share price recovery?

British American Tobacco Q4 Earnings Preview: The Dart Empire Strikes Back

International Wide-Moat Stocks On Sale - The February 2024 Heat Map

Philip Morris: Successful Pivot To Next-Generation Products

British American Tobacco: 2023 Results Reflect Multiple Positives

Imperial Brands: The 11.3% Forward Yield Is Attractive Despite Long-Term Risks

Imperial Brands Is Cheap, But We Are Not Buying

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>If you&rsquo;re looking for the top <a href="https://investorplace.com/industries/healthcare/cannabis/">cannabis stocks</a> to buy, I know an exchange traded fund (<span>ETF</span>) that has performed exceptionally well, relatively speaking, over the past three years. It&rsquo;s down <a href="https://www.nerdwallet.com/article/investing/marijuana-etfs">32.7%</a>, but that&rsquo;s better than all the other major cannabis ETFs available.&nbsp;</p>



<p>The ETF is the <strong>Cambria Cannabis ETF </strong>(BATS:<span><a href="https://investorplace.com/stock-quotes/toke-stock-quote/"><strong>TOKE</strong></a></span>), an <a href="https://www.cambriafunds.com/assets/docs/Cambria_TOKE_Summary.pdf">actively managed fund</a> launched in July 2019. It is managed by Mebane Faber, a well-known portfolio manager. Faber&rsquo;s Cambria Investment Management provides investors with 14 different ETFs, including TOKE, an aptly named stock symbol. </p>



<p>TOKE has over <a href="https://www.cambriafunds.com/TOKE">$9 million</a> in net assets, has a dividend yield of 4.31% and paid&nbsp;24 cents per share&nbsp;in 2023. If you&rsquo;re feeling aggressive, here are three individual stocks held by TOKE to consider investing in directly. But keep in mind that cannabis stocks remain a risky proposition.&nbsp;&nbsp;</p>



<h2><strong>Imperial Brands (IMBBF)</strong></h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/05/marijuana-joint-smoke-1600-300x169.jpg" alt="photo of a hand holding a marijuana joint that is smoking against a green outdoor background"><div>Source: shutterstock.com/Tunatura</div></div><p><strong>Imperial Brands </strong>(OTCMKTS:<span><a href="https://investorplace.com/stock-quotes/imbbf-stock-quote/"><strong>IMBBF</strong></a></span>) is the third-largest holding in TOKE and makes up 8.38% of the ETF. It has a market capitalization of $18.5 billion.&nbsp;</p>



<p>The company&rsquo;s main business is cigarettes. That&rsquo;s not everybody&rsquo;s cup of tea, but they generally provide consistent cash flow. Its cigarette brands include <a href="https://www.imperialbrandsplc.com/brands-of-choice">John Player Special</a>, Winston, Kool and L&amp;B. In cigars, it owns the Backwoods brand, well-known in the U.S. It owns the Blu brand in the vaping segment, acquired from Lorillard in 2015. In 2019, it created Pulze, a heated tobacco brand, and Skruf, a Swedish-created oral nicotine product.&nbsp;</p>



<p>Imperial dipped its toe in the newly regulated cannabis industry in 2022 by <a href="https://www.imperialbrandsplc.com/content/dam/imperialbrands/corporate/documents/key-announcements/2019/Next-Generation-Product-Portfolio-25-July-2019.pdf">partnering</a> with <strong>Auxly Cannabis Group </strong>(OTCMKTS:<span><a href="https://investorplace.com/stock-quotes/cbwtf-stock-quote/"><strong>CBWTF</strong></a></span>), a Toronto-based cannabis producer. Imperial invested 75 million British pounds (USD $95.5 million) while granting the Canadian company global licenses for its vaping technology.&nbsp;</p>



<p>Last July, the two companies agreed to extend the debenture by two years to Sept. 25, 2026. The debenture has a <a href="https://mjbizdaily.com/auxly-cannabis-imperial-brands-extend-maturity-date-of-debenture/">conversion price</a> of 81 Canadian cents (USD 60 cents), well above where it&rsquo;s currently trading. It continues to work on rightsizing its business. Revenues for the first nine months of 2023 were up <a href="https://www.prnewswire.com/news-releases/auxly-reports-q3-2023-financial-results-301985872.html">6%</a> over last year with a slight adjusted EBITDA loss, down 95% from a year ago.&nbsp;</p>



<h2>Scotts Miracle-Gro (SMG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/smg1600-300x169.jpg" alt="Scotts Miracle-Gro logo displayed on a web browser and magnified by a magnifying glass"><div>Source: Casimiro PT / Shutterstock.com</div></div><p><strong>Scotts Miracle-Gro </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/smg-stock-quote/"><strong>SMG</strong></a></span>) is the fifth-largest holding in TOKE and makes up 7% of the ETF. It has a market capitalization of $3.73 billion.</p>



<p>While the company is best known for its <a href="https://scottsmiraclegro.com/who-we-are/brands/">lawn care and gardening products</a> including Scotts, Miracle-Gro and Hyponex, its hydroponics business has recently dragged down its share price. It&rsquo;s down 20% over the past five years and 74% since hitting $250 in April 2021, the gold rush days for cannabis. The company reported <a href="https://scottsmiraclegro.gcs-web.com/news-releases/news-release-details/scottsmiracle-gro-reports-first-quarter-results-0">Q1 2024</a> results in early February. </p>



<p>&ldquo;As we look to the year ahead, we are focused on driving top-line growth, tightly controlling expenses and delivering on our targets for free cash flow generation, gross margin improvement and aggressive debt paydown,&rdquo; CEO Jim Hagedorn said in the company&rsquo;s quarterly press release.&nbsp;&nbsp;&ldquo;We are reaffirming our guidance of high-single digit growth in our consumer business, and in Hawthorne, we continue to take actions to ensure the business remains cash flow positive in fiscal 2024 and a major contributor to our debt paydown.&rdquo;</p>



<p>While the CEO would never admit it, Jim Hagedorn probably wishes he&rsquo;d taken a pass on creating the Hawthorne Gardening Company in <a href="https://www.globenewswire.com/en/news-release/2014/10/28/677361/33079/en/ScottsMiracle-Gro-Announces-Formation-of-The-Hawthorne-Gardening-Company.html">2014</a>. It nearly took down the parent due to <a href="https://mjbizdaily.com/scotts-miracle-gro-struggling-hawthorne-seeks-marijuana-ma-deals/">$1.7 billion</a> in cannabis investments that have yet to pan out.&nbsp;</p>



<p>However, the core business is sound, and if Hawthorne can hang in there long enough to see federal marijuana reform, the shares are incredibly undervalued, but only for aggressive investors.&nbsp;While it might not currently be performing, with a little luck it could soon be one of the top cannabis stocks to buy.</p>



<h2><strong>Innovative Industrial Properties (IIPR)</strong></h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/aurora-cannabis-stock-7-300x169.jpg" alt="A close-up shot of a marijuana growhouse. cannabis trends"><div>Source: Shutterstock</div></div><p><strong>Innovative Industrial Properties </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/iipr-stock-quote/"><strong>IIPR</strong></a></span>) is the ninth-largest holding in TOKE and makes up 4.9% of the ETF. It has a market capitalization of $2.74 billion.&nbsp;</p>



<p>The San Diego-based real estate investment trust (<span>REIT</span>) finished 2023 with revenue of $309.5 million, 12% higher than in 2022. Also, its adjusted funds from operations (<span>AFFO</span>) in 2023 were 10% higher year-over-year (YOY) at <a href="https://investors.innovativeindustrialproperties.com/press-releases/2024/02-26-2024-214913474">$256.5 million</a>.&nbsp;</p>



<p>Based on an AFFO of $9.08 a share, the REIT&rsquo;s shares trade at just 10.7x this cash flow. That&rsquo;s low, given what kind of year it&rsquo;s delivered for shareholders. The owner of industrial properties tenanted by licensed cannabis producers continues to be caught in the undertow faced by an industry that produced way too much inventory.&nbsp;&nbsp;</p>



<p>It ended 2023 with 108 properties in 19 states and 8.9 million rentable square feet of space. It collected 100% of the base rents and property management fees due in the fourth quarter.&nbsp;In addition, it finished the year with approximately $312 million in debt, just 12% of its $2.6 billion in total gross assets, none of which mature before May 2026.&nbsp;</p>



<p>With triple-net leases in place and 95.8% occupancy, weighted-average lease terms remaining of 14.6 years and no tenant accounting for more than 16% of its base rent, it&rsquo;s in excellent shape as far as REITs go. This says to me that IIPR is not only the best cannabis stock to buy right now but also the cheapest and safest. It also currently yields 7.91%, making it the best in this bunch of top cannabis stocks to buy.</p>



<p><em>On the date of publication, Will Ashworth did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"> Publishing Guidelines</a>.</em></p>
<div><p>Will Ashworth has written about investments full-time since 2008. Publications where he&rsquo;s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He particularly enjoys creating model portfolios that stand the test of time. He lives in Halifax, Nova Scotia.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT793994">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793989">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793998">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/03/the-top-3-cannabis-stocks-to-buy-in-march-2024/">The Top 3 Cannabis Stocks to Buy in March 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>